Literature DB >> 21651595

Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life.

D J Kearney1, K McDermott, M Martinez, T L Simpson.   

Abstract

BACKGROUND: Stress perception and GI-specific anxiety play key roles in irritable bowel syndrome (IBS). Mindfulness-based stress reduction (MBSR) is a widely available stress reduction course, which has not been evaluated for IBS. AIM: To determine whether participation in MBSR is associated with improvement in bowel symptoms, GI-specific anxiety, and IBS-Quality of Life.
METHODS: This is a prospective study of 93 participants in MBSR. We applied measures of Rome III IBS status, bowel symptoms (IBS-Severity Scoring System, IBS-SSS), IBS-Quality of Life (IBS-QOL), GI-specific anxiety (Visceral Sensitivity Index, VSI), mindfulness (Five Facet Mindfulness Questionnaire-FFMQ), and functional status (SF-8) at baseline and 2 and 6 months after enrolment.
RESULTS: At 2 months, participation in MBSR was associated with small nonsignificant changes in IBS-SSS, IBS-QOL and VSI: d = -0.25, d = 0.08, d = -0.16, respectively. At 6 months, there was no significant change in IBS-SSS (d = -0.36); whereas for IBS-QOL and VSI there were significant improvements (IBS-QOL: d = 0.33, P = 0.044; VSI: d = -0.40, P = 0.014). For patients meeting Rome III IBS criteria (n = 43), changes in IBS-SSS, IBS-QOL and VSI were not statistically significant, but there was a significant correlation between the change in VSI and the change in FFMQ across the three time periods (r = 0.33).
CONCLUSIONS: Participation in MBSR is associated with improvement IBS-related quality of life and GI-specific anxiety. Randomised controlled trials are warranted to further assess the role of MBSR for IBS symptomatology. Published 2011.This article is a US Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2011        PMID: 21651595     DOI: 10.1111/j.1365-2036.2011.04731.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  17 in total

Review 1.  Meditation over medication for irritable bowel syndrome? On exercise and alternative treatments for irritable bowel syndrome.

Authors:  Fredrick Asare; Stine Störsrud; Magnus Simrén
Journal:  Curr Gastroenterol Rep       Date:  2012-08

2.  Mindfulness-based stress reduction in an integrated care delivery system: one-year impacts on patient-centered outcomes and health care utilization.

Authors:  Tracy Mccubbin; Sona Dimidjian; Karin Kempe; Melissa S Glassey; Colleen Ross; Arne Beck
Journal:  Perm J       Date:  2014

Review 3.  Prospects for a clinical science of mindfulness-based intervention.

Authors:  Sona Dimidjian; Zindel V Segal
Journal:  Am Psychol       Date:  2015-10

4.  Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial.

Authors:  Kristin A Zernicke; Tavis S Campbell; Philip K Blustein; Tak S Fung; Jillian A Johnson; Simon L Bacon; Linda E Carlson
Journal:  Int J Behav Med       Date:  2013-09

5.  Visceral pain perception in patients with irritable bowel syndrome and healthy volunteers is affected by the MRI scanner environment.

Authors:  Reuben K Wong; Lukas Van Oudenhove; Xinhua Li; Yang Cao; Khek Yu Ho; Clive H Wilder-Smith
Journal:  United European Gastroenterol J       Date:  2015-04-09       Impact factor: 4.623

6.  Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals.

Authors:  Raymond Addante; Bruce Naliboff; Wendy Shih; Angela P Presson; Kirsten Tillisch; Emeran A Mayer; Lin Chang
Journal:  J Clin Gastroenterol       Date:  2019-04       Impact factor: 3.062

Review 7.  Mindfulness and physical disease: a concise review.

Authors:  Jeffrey M Greeson; Gabrielle R Chin
Journal:  Curr Opin Psychol       Date:  2018-12-27

8.  Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety.

Authors:  Ling Lan; Yu-Long Chen; Hao Zhang; Bai-Ling Jia; Yan-Jun Chu; Jin Wang; Shi-Xiao Tang; Guo-Dong Xia
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

9.  The Level of Public Knowledge about Inflammatory Bowel Disease in Christchurch, New Zealand.

Authors:  Angharad Vernon-Roberts; Richard B Gearry; Andrew S Day
Journal:  Inflamm Intest Dis       Date:  2020-09-16

10.  Mindfulness-based interventions for physical conditions: a narrative review evaluating levels of evidence.

Authors:  Linda E Carlson
Journal:  ISRN Psychiatry       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.